The SpineJack® is becoming a standard for the treatment of vertebral fractures and VEXIM’s technology has been embraced by several key opinion leaders. We can already confirm we have reached the milestone of 40,000 implants sold – which represents approximatively more than 20,000 patients.
We will build on this success and on our leading technology platform to extend our product offering and target new pathologies in spine trauma by 2018.